Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased

Daily Values

Growth Metrics

Neuraxis (NRXS) Depreciation and Depletion (2022 - 2023)

Neuraxis (NRXS) has disclosed Depreciation and Depletion for 2 consecutive years, with $7814.0 as the latest value for Q4 2023.

Quarterly Depreciation and Depletion rose 6.63% to $7814.0 in Q4 2023 from the year-ago period, while the trailing twelve-month figure was $30340.0 through Dec 2023, changed N/A year-over-year, with the annual reading at $26346.0 for FY2024, 12.88% down from the prior year.
Depreciation and Depletion hit $7814.0 in Q4 2023 for Neuraxis, up from $7609.0 in the prior quarter.
In the past five years, Depreciation and Depletion ranged from a high of $7868.0 in Q3 2022 to a low of $7328.0 in Q4 2022.